Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome
Identifieur interne : 000315 ( France/Analysis ); précédent : 000314; suivant : 000316Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome
Auteurs : M. A. Bedard [Canada] ; B. Pillon [France] ; B. Dubois [France] ; N. Duchesne [Canada] ; H. Masson [Canada] ; Yves Agid [France]Source :
- Brain and cognition [ 0278-2626 ] ; 1999.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Acute Disease, Chemotherapy, Cholinergic Antagonists (therapeutic use), Cholinergic transmission, Cognition Disorders (chemically induced), Cognition Disorders (diagnosis), Cognitive disorder, Corpus Striatum (pathology), Cross-Over Studies, Dose-Response Relationship, Drug, Double-Blind Method, Executive function, Frontal lobe, Human, Humans, Hyoscine, Levodopa (therapeutic use), Middle Aged, Nerve Degeneration, Neuropsychological Tests, Parkinson Disease (drug therapy), Parkinson Disease (pathology), Parkinson disease, Scopolamine Hydrobromide (adverse effects), Severity of Illness Index, Subcortex, Substantia Nigra (pathology), Syndrome, Time Factors, Treatment, Trihexyphenidyl, Trihexyphenidyl (adverse effects).
- MESH :
- chemical , adverse effects : Scopolamine Hydrobromide, Trihexyphenidyl.
- chemical , therapeutic use : Cholinergic Antagonists, Levodopa.
- chemically induced : Cognition Disorders.
- diagnosis : Cognition Disorders.
- drug therapy : Parkinson Disease.
- pathology : Corpus Striatum, Parkinson Disease, Substantia Nigra.
- Acute Disease, Cross-Over Studies, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Middle Aged, Nerve Degeneration, Neuropsychological Tests, Severity of Illness Index, Syndrome, Time Factors.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000D33
- to stream PascalFrancis, to step Curation: 001190
- to stream PascalFrancis, to step Checkpoint: 000C75
- to stream Main, to step Merge: 003E28
- to stream PubMed, to step Corpus: 001702
- to stream PubMed, to step Curation: 001702
- to stream PubMed, to step Checkpoint: 001702
- to stream Ncbi, to step Merge: 000036
- to stream Ncbi, to step Curation: 000036
- to stream Ncbi, to step Checkpoint: 000036
- to stream Main, to step Merge: 003C04
- to stream Main, to step Curation: 003841
- to stream Main, to step Exploration: 003841
- to stream France, to step Extraction: 000315
Links to Exploration step
Pascal:99-0503529Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome</title><author><name sortKey="Bedard, M A" sort="Bedard, M A" uniqKey="Bedard M" first="M. A." last="Bedard">M. A. Bedard</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre de neuroscience de la cognition, UQAM, and Laboratoire de Neuropharmacologie Cognitive, Hôpital Notre-Dame</s1><s2>Montréal</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM U-289, Hôpital de la Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM U-289, Hôpital de la Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Duchesne, N" sort="Duchesne, N" uniqKey="Duchesne N" first="N." last="Duchesne">N. Duchesne</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre de neuroscience de la cognition, UQAM, and Laboratoire de Neuropharmacologie Cognitive, Hôpital Notre-Dame</s1><s2>Montréal</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Masson, H" sort="Masson, H" uniqKey="Masson H" first="H." last="Masson">H. Masson</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre de neuroscience de la cognition, UQAM, and Laboratoire de Neuropharmacologie Cognitive, Hôpital Notre-Dame</s1><s2>Montréal</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM U-289, Hôpital de la Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">99-0503529</idno><date when="1999">1999</date><idno type="stanalyst">PASCAL 99-0503529 INIST</idno><idno type="RBID">Pascal:99-0503529</idno><idno type="wicri:Area/PascalFrancis/Corpus">000D33</idno><idno type="wicri:Area/PascalFrancis/Curation">001190</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000C75</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000C75</idno><idno type="wicri:doubleKey">0278-2626:1999:Bedard M:acute:and:long</idno><idno type="wicri:Area/Main/Merge">003E28</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:10413563</idno><idno type="wicri:Area/PubMed/Corpus">001702</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001702</idno><idno type="wicri:Area/PubMed/Curation">001702</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001702</idno><idno type="wicri:Area/PubMed/Checkpoint">001702</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001702</idno><idno type="wicri:Area/Ncbi/Merge">000036</idno><idno type="wicri:Area/Ncbi/Curation">000036</idno><idno type="wicri:Area/Ncbi/Checkpoint">000036</idno><idno type="wicri:doubleKey">0278-2626:1999:Bedard M:acute:and:long</idno><idno type="wicri:Area/Main/Merge">003C04</idno><idno type="wicri:Area/Main/Curation">003841</idno><idno type="wicri:Area/Main/Exploration">003841</idno><idno type="wicri:Area/France/Extraction">000315</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome</title><author><name sortKey="Bedard, M A" sort="Bedard, M A" uniqKey="Bedard M" first="M. A." last="Bedard">M. A. Bedard</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre de neuroscience de la cognition, UQAM, and Laboratoire de Neuropharmacologie Cognitive, Hôpital Notre-Dame</s1><s2>Montréal</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM U-289, Hôpital de la Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM U-289, Hôpital de la Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Duchesne, N" sort="Duchesne, N" uniqKey="Duchesne N" first="N." last="Duchesne">N. Duchesne</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre de neuroscience de la cognition, UQAM, and Laboratoire de Neuropharmacologie Cognitive, Hôpital Notre-Dame</s1><s2>Montréal</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Masson, H" sort="Masson, H" uniqKey="Masson H" first="H." last="Masson">H. Masson</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre de neuroscience de la cognition, UQAM, and Laboratoire de Neuropharmacologie Cognitive, Hôpital Notre-Dame</s1><s2>Montréal</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>INSERM U-289, Hôpital de la Salpêtrière</s1><s2>Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author></analytic><series><title level="j" type="main">Brain and cognition</title><title level="j" type="abbreviated">Brain cogn.</title><idno type="ISSN">0278-2626</idno><imprint><date when="1999">1999</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Brain and cognition</title><title level="j" type="abbreviated">Brain cogn.</title><idno type="ISSN">0278-2626</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Chemotherapy</term><term>Cholinergic Antagonists (therapeutic use)</term><term>Cholinergic transmission</term><term>Cognition Disorders (chemically induced)</term><term>Cognition Disorders (diagnosis)</term><term>Cognitive disorder</term><term>Corpus Striatum (pathology)</term><term>Cross-Over Studies</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Executive function</term><term>Frontal lobe</term><term>Human</term><term>Humans</term><term>Hyoscine</term><term>Levodopa (therapeutic use)</term><term>Middle Aged</term><term>Nerve Degeneration</term><term>Neuropsychological Tests</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (pathology)</term><term>Parkinson disease</term><term>Scopolamine Hydrobromide (adverse effects)</term><term>Severity of Illness Index</term><term>Subcortex</term><term>Substantia Nigra (pathology)</term><term>Syndrome</term><term>Time Factors</term><term>Treatment</term><term>Trihexyphenidyl</term><term>Trihexyphenidyl (adverse effects)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Scopolamine Hydrobromide</term><term>Trihexyphenidyl</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cholinergic Antagonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Corpus Striatum</term><term>Parkinson Disease</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Cross-Over Studies</term><term>Dose-Response Relationship, Drug</term><term>Double-Blind Method</term><term>Humans</term><term>Middle Aged</term><term>Nerve Degeneration</term><term>Neuropsychological Tests</term><term>Severity of Illness Index</term><term>Syndrome</term><term>Time Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term><term>Lobe frontal</term><term>Souscortex</term><term>Trouble cognition</term><term>Fonction exécutive</term><term>Chimiothérapie</term><term>Traitement</term><term>Transmission cholinergique</term><term>Trihexyphénidyle</term><term>Scopolamine</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Canada</li><li>France</li></country><region><li>Québec</li><li>Île-de-France</li></region><settlement><li>Montréal</li><li>Paris</li></settlement><orgName><li>Hôpital de la Salpêtrière</li></orgName></list><tree><country name="Canada"><region name="Québec"><name sortKey="Bedard, M A" sort="Bedard, M A" uniqKey="Bedard M" first="M. A." last="Bedard">M. A. Bedard</name></region><name sortKey="Duchesne, N" sort="Duchesne, N" uniqKey="Duchesne N" first="N." last="Duchesne">N. Duchesne</name><name sortKey="Masson, H" sort="Masson, H" uniqKey="Masson H" first="H." last="Masson">H. Masson</name></country><country name="France"><region name="Île-de-France"><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name></region><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000315 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000315 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= Pascal:99-0503529
|texte= Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome
}}
| This area was generated with Dilib version V0.6.29. |  |